Seelos Therapeutics Inc. buy Quitte
Start price
09.03.17
/
50%
€90.65
Target price
16.03.17
€89.30
Performance (%)
-31.64%
End price
16.03.17
€61.97
Summary
This prediction ended on 16.03.17 with a price of €61.97. The BUY prediction by Quitte for Seelos Therapeutics Inc. performed very badly with a performance of -31.64%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Seelos Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | -0,38 % | 2,61 % | 11,34 % | 61,27 % |
| iShares Nasdaq 100 | -0,41 % | -2,00 % | 5,35 % | 90,63 % |
| iShares Nikkei 225® | 1,84 % | 9,39 % | 33,53 % | 67,98 % |
| iShares S&P 500 | -0,71 % | -0,48 % | 2,51 % | 62,52 % |
Comments by Quitte for this prediction
In the thread Seelos Therapeutics Inc. diskutieren
könnte mal was werden
http://www.finanznachrichten.de/nachrichten-2017-03/40130895-apricus-biosciences-inc-apricus-biosciences-announces-sale-of-ex-u-s-vitaros-assets-and-rights-to-ferring-pharmaceuticals-252.htm
(Vom Mitglied beendet)
Stopped prediction by Quitte for Seelos Therapeutics Inc.
Seelos Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.39
25.03.19
25.03.19
€3.25
01.04.19
01.04.19
19.65%
01.04.19
01.04.19
Seelos Therapeutics Inc.
Start price
Target price
Perf. (%)
€46.00
18.11.16
18.11.16
€51.41
02.12.16
02.12.16
-20.00%
02.12.16
02.12.16